Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
In the first year following diagnosis, we found increased cumulative incidence risk ratios in a number of outcomes including: - Any mental, behavioural, or neurodevelopmental disorder 1.96 (1.93 - 1.99) - Postpartum depression 2.70 (2.61 - 2.79) - Eating disorders 2.06 (1.85 - 2.89) - PTSD 1.77 (1.69 - 1.86) We also saw significantly increased risk in rare but serious outcomes such as: - Wernicke's encephalopathy 2.39 (1.25 - 4.56) - Puerperal psychosis 1.80 (1.48 - 2.20) Interestingly, cases of hyperemesis gravidarum with metabolic disturbance displayed a significantly lower risk of any depression and postpartum depression compared with those without metabolic disturbance
Badenhorst T, Svirskis D, Merrilees M, Bolke L, Wu Z
Long-term safety studies, however, have not been conducted (see Concerns and Cautions)
The College of Physicians and Surgeons of British Columbia said it doesn't have specific guidance on prescribing oral BPC-157, but expects "licensees to exercise professional judgment to ensure they are providing safe and appropriate patient care." U.S
US$ 21.21
US$ 24.53
US$ 25.47
